Singapore Diagnostic Labs Market
Singapore Diagnostic Labs Market Size Booming to Reach USD 3.6 Billion by 2030
Published | 18 July 2024
Singapore Diagnostic Labs Market is flourishing because of the increasing government and private sector investment in healthcare infrastructure and growing prevalence of chronic diseases.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Singapore Diagnostic Labs Market size at USD 2.2 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Singapore Diagnostic Labs Market size to expand at a CAGR of 8.38% reaching a value of USD 3.6 billion by 2030. Rapidly aging population, a growing emphasis on early diagnosis, and increased incidences of both communicable and non-communicable illnesses as a result of changing lifestyles are major growth factors for Singapore Diagnostic Labs Market. Over the projected period, public-private investments in the development of healthcare infrastructure are also expected to propel the Diagnostic Labs Market in Singapore.
Opportunity - Increasing prevalence of chronic and communicable diseases
The rising incidence of several chronic and non-communicable illnesses in the country directly influences the growth of Singapore Diagnostic Labs Market. As per an industry estimate, there are currently over 400,000 individuals in Singapore who have diabetes, and by 2050, that figure is expected to increase to one million. According to the National Cancer Centre Institute, there were 84,002 cancer cases recorded in Singapore between 2017 and 2021, indicating a significant increase in the country's cancer incidence. Consequently, there was a surge in the country's need for preventative measures like periodic checks, which is driving up demand for diagnostic laboratories in Singapore.
Sample Request @ https://www.blueweaveconsulting.com/report/singapore-diagnostic-labs-market/report-sample
Radiology Test to Grow at Fastest CAGR During 2024–2030
Singapore Diagnostic Labs Market consists of routine tests, pathology tests, and radiology tests segments on the basis of test type. The radiology segment is anticipated to register a high growth rate during the forecast period. Radiology test type is also used to diagnose and treat diseases and monitor the response of the body to the treatment. The increasing prevalence of various cancer types, such as breast cancer, and colon cancer, is propelling the demand for radiology tests in Singapore.
Impact of Escalating Geopolitical Tensions on Singapore Diagnostic Labs Market
Escalating geopolitical tensions can significantly impact the growth of Singapore Diagnostic Labs Market. Trade disruptions, such as tariffs and import restrictions, can lead to higher costs for diagnostic labs, affecting both supply and pricing. For instance, tensions between major global economies like the United States and China can create ripple effects. Heightened geopolitical tensions might divert Singapore government’s focus and resources from market development initiatives toward defense and security, indirectly stalling the growth and innovations in Singapore Diagnostic Labs Market.
Competitive Landscape
Major companies in Singapore Diagnostic Labs Market include Innoquest Diagnostics Pte Ltd, Raffles Diagnostics Pte Ltd, Parkway Laboratory Services Ltd, Quest Laboratories Pte Ltd, National Healthcare Group Diagnostics, Pathology & Clinical Laboratory Pte Ltd, Reste Laboratories Pte Ltd, Biomedics Laboratory Pte Ltd, Acumen Diagnostics Pte Ltd, and Singapore Diagnostics.
To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and Singapore Diagnostic Labs Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Singapore Diagnostic Labs Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2023 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
Revenue in USD Billion |
Product/ Service Segmentation |
Provider Type, Test Type, End User |
Key Players |
Innoquest Diagnostics Pte Ltd, Raffles Diagnostics Pte Ltd, Parkway Laboratory Services Ltd, Quest Laboratories Pte Ltd, National Healthcare Group Diagnostics, Pathology & Clinical Laboratory Pte Ltd, Reste Laboratories Pte Ltd, Biomedics Laboratory Pte Ltd, Acumen Diagnostics Pte Ltd, Singapore Diagnostics |
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: July 2024
Increasing investments by government and private sector in the further development of healthcare infrastructure and a growing emphasis on the treatment and better management of rising prevalence of chronic diseases are expected to boost the growth of Singapore Diagnostic Labs Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- Middle East and Africa Medical Imaging Software Market Size Set to Grow at Significant CAGR of 7.64% Touching USD 430.99 Million by 2029
- India Oncology Drugs Market Size Booming at Significant CAGR of almost 8% to Touch USD 3.75 Billion by 2030
- Pharmaceutical Excipients Market is Forecast to Grow at a CAGR of 5.80% in the Forecast Period
- Global Wound Closure Product Market Expected to Reach US$ 16,077 Million by 2024
- Global Microbiome Therapeutics Market to Boom at Robust CAGR to Cross USD 746 Million by 2028